TRAW Earnings

Quarterly EPS
$-1.49
Q3 2024
$-6.31
Q4 2024
$2.17
Q1 2025
$-0.11
Q2 2025
$-0.34
Q3 2025
$-0.48
Q4 2025
$-0.53
Q1 2026
$-0.16
Q2 2026
Latest RevenueN/A
Latest Net Income-3054000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.160-3054000-100.0%-45.5%
Q1 2026-$0.530-7107000-100.0%-124.4%
Q4 2025-$0.480-7443000-100.0%+92.4%
Q3 2025-$0.340-3962000-100.0%+77.2%
Q2 2025-$0.112.7M-915000+4,694.7%+99.5%
Q1 2025$2.1757.0K21.5M
Q4 2024-$6.3156.0K-29922000
Q3 2024-$1.4957.0K-8475000
Q2 2024-$20.5257.0K-123143000
Traws Pharma (TRAW) — Earnings